|
 Services |
|
|
 |
Subscribe |
|
|
|
|
|
|
Response |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Information
For |
|
|
|
|
|
|
|
|
| About
JCIM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Journal of Chinese Integrative Medicine: 2010; 8(7): 636-640
DOI: 10.3736/jcim20100706 |
|
| Effects of moxibustion at head-points on levels of somatostatin and arginine vasopressin from cerebrospinal fluid in patients with vascular dementia: a randomized controlled trial |
| 1. | Pin Wang (School of Acupuncture and Osteology, Anhui University of Traditional Chinese Medicine, Hefei 230038, Anhui Province, China E-mail: wangpin1890@163.com) | | 2. | Jun Yang (Acupuncture Hospital, Anhui University of Traditional Chinese Medicine, Hefei 230061, Anhui Province, China ) | | 3. | Gang Liu (Acupuncture Hospital, Anhui University of Traditional Chinese Medicine, Hefei 230061, Anhui Province, China ) | | 4. | Hao Chen (Acupuncture Hospital, Anhui University of Traditional Chinese Medicine, Hefei 230061, Anhui Province, China ) | | 5. | Fan Yang (School of Acupuncture and Osteology, Anhui University of Traditional Chinese Medicine, Hefei 230038, Anhui Province, China ) |
|
|
Background: There are obvious changes in neuropeptides from plasma and cerebrospinal fluid in patients with vascular dementia (VaD), and regulating the levels of neuropeptides is a key for prevention and treatment of VaD.
Objective: To observe the clinical efficacy of moxibustion at head-points in treatment of vascular dementia (VaD), and assess its effects on memory-related neuropeptides.
Design, setting, participants and interventions: A total of 65 VaD patients from Acupuncture Hospital, Anhui University of Traditional Chinese Medicine, were randomly divided into moxibustion group (33 cases) and Western medicine group (32 cases). Patients in the moxibustion group were treated with indirect moxibustion with common monkshood cake for 20 min. Patients in the Western medicine group were orally administered piracetam tablets, 0.8 g for three times a day. One treatment course was 4 weeks, and they were treated for 4 treatment courses.
Main outcome measures: The scores of Hasegawa’s Dementia Scale (HDS), Mini-Mental State Examination (MMSE), and Activity of Daily Living Scale (ADL), as well as the levels of learning and memory-related neuropeptides from cerebrospinal fluid such as somatostatin (SS) and arginine vasopressin (AVP) were measured before and after treatment in the two groups.
Results: Total response rate was significantly higher in the moxibustion group than in the Western medicine group (P<0.01). There were significant differences in scores of HDS, MMSE and ADL between before and after treatment in the two groups(P＜0.05 or P＜0.01). After treatment, the scores of HDS, MMSE and ADL in the moxibustion group were more improved as compared with those in the Western medicine group (P＜0.05 or P＜0.01). The levels of SS and AVP after treatment were higher than those before treatment in the two groups(P＜0.01). After treatment, the increased levels of SS and AVP were higher in the moxibustion group than in the Western medicine group (P<0.01).
Conclusion: Moxibustion is effective in improving the clinical symptom scores and regulating the levels of neuropeptides associated with learning and memory in VaD patients. |
|
| Welcome to JCIM! You are the number
455
reader of this article! |
|
| Download Article: |
| [Full Text] [PDF] [Chinese] [Previous] [Next] [This Issue] |
|
| Please cite this article as: |
| Wang P, Yang J, Liu G, Chen H, Yang F. Effects of moxibustion at head-points on levels of somatostatin and arginine vasopressin from cerebrospinal fluid in patients with vascular dementia: a randomized controlled trial. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2010; 8(7): 636-640. |
|
| References:
|
| 1 | Lu YW, Li ZX, Rong BB. Neuropetides and vascular dementia[J].Yi Xue Zong Shu, 2006, 12(6): 348-350. Chinese with abstract in English. |
| 2 | Baldereschi M, Amato MP, Nencini P, Pracucci G, Lippi A, Amaducci L, Gauthier S, Beatty L, Quiroga P, Klassen G, Galea A, Muscat P, Osuntokun B, Ogunniyi A, Portera-Sanchez A, Bermejo F, Hendrie H, Burdine V, Brashear A, Farlow M, Maggi S, Katzman R. WHO-PRA Age-Associated Dementia Working Group, WHO Program for Research on Aging, Health of Elderly Program. Cross-national interrater agreement on the clinical diagnostic criteria for dementia[J].Neurology, 1994, 44(2): 239-242. . |
| 3 | Li WH. Criteria for clinical neurological impairment score in patients with cerebral apoplexy (1995)[J].Zhonghua Shen Jing Ke Za Zhi, 1996, 29(6): 381. Chinese. |
| 4 | Liang YD. Revised Hasegawa Dementia Scale for diagnosis of dementia[J].Riben Yi Xue Jie Shao, 1992, 13(9): 420. Chinese. |
| 5 | State Bureau of Technical Supervision. National standard of People’s Republic of China: location of points[M]. Beijing: Standards Press of China, 1990. Chinese. |
| 6 | Gao SR, Yuan JM. Diagnostics and treatment of dementia[M]. Beijing: Beijing Science and Technology Press, 1998. 79. Chinese. |
| 7 | Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome[J].Am Geriatr Soc, 1997, 45(3): 321-328. . |
| 8 | Ministry of Health of the People’s Republic of China. Guidelines for clinical research on Chinese new herbal medicines[M]. Beijing: China Medical Science and Technology Press, 2000. Chinese. |
| 9 | Yin XL, Li H, Jiao XM. Acupuncture treatment of vascular dementia research[J].Shi Yong Zhong Yi Nei Ke Za Zhi, 2009, 23(5): 5-6. Chinese with abstract in English. |
| 10 | Wang JZ, Li Q, Gao C, Gao D, Zhang LL, Zhou HJ, Yao GE. Study on activity changes of angiotensinⅡ and arginine vasopresin in cerebrospinal fluid and its correlation with P300 peak latency in 50 patients with vascular dementia[J].Zhongguo Lin Chuang Kang Fu, 2003, 7(10): 1500-1505. Chinese with abstract in English. |
|
|
|
|
|
|